Home >> Report Store >> Healthcare >> Intravenous Immunoglobulin Market, By Disease Types (CIDP, >

Intravenous Immunoglobulin Market Size Worth $14.7 Billion By 2025 | CAGR: 6.3%

Published Date : 14 / 12 / 17  | Report Format: PDF

The global intravenous immunoglobulin market is expected to grow at growth rate of 6.3% to reach USD 14.7 billion by 2025.

Intravenous immunoglobulin (IVIG), also called as gamma globulin, is a human plasma product, specifically used for the treatment of immunodeficiency-related disorders. It is highly purified blood derived product preparation. Immunoglobulins are categorized as immunoglobulin A, immunoglobulin M, immunoglobulin D, immunoglobulin G, and immunoglobulin E, divided based on the variety of heavy chain these molecules contain. The growth of IVIG market is majorly driven by the rise in the incidence rate of immunodeficiency diseases. As per the Immune Deficiency Foundation (IDF), there are more than 250 rare immune disorders representing primary immunodeficiency disorders.The growth of this market is also attributed to the increasing incidences bleeding and autoimmune disorders, aging population, and development of new treatment indications such as myasthenia gravis. According to the estimates published by the WHO, the global population of people aged 65 years and above was 7% in 2000 and is expected to rise to 16% in 2050.  However, high cost coupled with stringent regulations associated with IVIG therapy hampers the market growth over the future period.

To access report highlight and table of content of this report, please click the link below:


Key takeaways:

  • Hypogammaglobulinemia is considered to be the largest market, accounted for around 1.6 billion in 2017
  • IVIG therapy for the treatment of Congenital AIDS is growing significantly, i.e. 7.9% over the forecast period
  • Increasing number of government and non-government authorities researching on IVIG products support the market growth in Europe. Authorities such as Plasma Protein Therapeutics Association (PPTA) and Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA) regulate the IVIG products which provide healthy platform for the market growth in the European country.
  • Competition in this market is considerably high. Companies such as Shire, Octapharma, CSL and Grifols are competing to capture significant revenue share
  • Rising regulatory approvals for new therapeutics is considered to help companies in capturing large customer base. For instance, in January 2015, Grifols SA’s purification plant received the FDA approval for the production of intravenous immunoglobulin (IVIG) 10%, plasma protein marketed under brands Gamunex and Flebogamma.


  • Understanding of the strategies that are being adopted by the key players in this market to stay competitive
  • Extensive analysis of the key players dominating the competitive landscape of this market
  • In-depth analysis of the key factors are propelling the growth of the global market
  • Detailed analysis of the geographic region that will witness the strongest growth
  • Granular analysis of the current market scenario and the expected market grow

The scope of this report covers the market by its major segments, which include as follows:

Market Segmentation


  • Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
  • Hypogammaglobulinemia
  • Congenital AIDS
  • Immunodeficiency diseases
  • Chronic Lymphocytic Leukemia
  • Myasthenia Gravis
  • Multifocal motor neuropathy
  • Others


  • Intravenous
  • Subcutaneous


  • North America
  • Europe
  • Asia Pacific
  • Rest of the World


  • Further Breakdown of The North America Market
    • U.S.
    • Canada
  • Further Breakdown of The Europe Market
    • Germany
    • France
    • Rest of Europe
  • Further Breakdown of The APAC Market
    • India
    • China
    • Rest of APAC
  • Further Breakdown of The Rest of the World Market
    • Middle East and Africa
    • Latin America

Why AnalystView?


Trusted Partnership

We strive to become one of the trusted partner of our client by offering value added services and concrete research data.


Tailor Made Solutions

From single reports and data downloads to enterprise subscriptions to custom consultancy, we can base our precise solutions round our client’s exact needs.

Turnaround Time

Our analyst aims to provide research studies in quickest turnaround time and in a much cost effective manner.


Data Accuracy And Reliability

We utilize a mix of primary, secondary research, and machine learning algorithms to generate accurate and comprehensive data about market size and revenue forecasts.

Competitive Pricing

We offer most competitive pricing policy across the research industry

Client Testimonials

Asia Pacific based Chemical Industry (Privacy Requested)

Thanks AnalystView for putting a great team to work on our research projects. It was a smooth transition of knowledge and delivery was seamless. We are keen to work with you on our upcoming projects. Thank you once again for the professional attitude your team has demonstrated.

CEO, Europe based Digital Media Company (Privacy Requested)

We had confusion after receiving the final data sheet of report. As per some preliminary we already have, we believe the market is over estimated.. However, after string of calls with analyst, we found their final research analysis was methodologically sound and their work to be very professional and up […]

Managing Director, Chemical based Company, Asia Pacific (Privacy Requested)

We are happy with the way the AnalystView member understood the brief and went about executing our research project.

U.S. Headquartered Medical Device Company (Privacy Requested)

AnalystView team has done brand assessment study for blood glucose monitoring devices market, in which we want enter into….We were very impressed not only by their research skills but also by their understanding of issues relevant to our requirements…!!

Vice President, Petrochemical Firm based in China (Privacy Requested)

It was a pleasure assigning project to AnalystView; they are reliable, fast and friendly. Highly recommend this company for research workJGood stuff!

US based healthcare service provider (Privacy Requested)

Frankly, we didn’t expect much comprehensive data for the report we purchased. To be surprised, I must say the report we received was very nicely executed….It contains all the information we are looking for and satisfied with the quality of the report. Thank you team

Europe based Chemical Industry (Privacy Requested)

Just wanted to say massive thanks for all the help from the AnalystView team. We purchased two reports one is Food Safety Testing report and another one is Enzyme market. These reports have helped us build a sound knowledge base of our business segments and have taken our business to […]

Why Choose Us

We devise research report with quality data:

Combined with an in-depth knowledge of the current industry and a sharp analytical mind, AnalystView serve our customer accurate research in accordance with a constantly evolving industry.

We work with businesses just like yours: 

AnalystView committed to making a positive difference for our clients. This means whatever you demand, chances are we already have experience with something similar.

Share This